Abstract
The term schizoaffective disorder has been generally applied to individuals with coexisting features of schizophrenia and a mood disorder but has been variously defined. Studies of phenomenology, clinical course, and heritability, when taken together, are consistent with the view that a majority of individuals who meet criteria for schizoaffective disorder have, in fact, either schizophrenia or a mood disorder with psychotic features, and that a minority suffer from a genotypic concurrence of both illnesses. The treatment of individuals with schizoaffective disorder should initially assume the presence of a psychotic mood disorder, however.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference
Spitzer RL, Endicott J, Robins E. Research diagnostic criteria. Psychopharmacol Bull 1975;11(3):22–25.
Coryell W, Endicott J, Keller M, Andreasen NC. Phenomenology and family history in DSM-III psychotic depression. J Affect Disord 1985;9(1):13–18.
Clayton PJ, Rodin L, Winokur G. Family history studies. 3. Schizoaffective disorder, clinical and genetic factors including a one to two year follow-up. Compr Psychiatry 1968;9(1):31–49.
Pope HG, Jr., Lipinski JF, Cohen BM, Axelrod DT. ‘‘Schizoaffective disorder”: an invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia, and affective disorder. Am J Psychiatry 1980;137(8):921–927.
Clayton PJ. Schizoaffective disorders. J Nerv Ment Dis 1982;170(11):646–650.
Coryell W, Keller M, Lavori P, Endicott J. Affective syndromes, psychotic features, and prognosis. I. Depression. Arch Gen Psychiatry 1990;47(7):651–657.
Coryell W, Keller M, Lavori P, Endicott J. Affective syndromes, psychotic features, and prognosis. II. Mania. Arch Gen Psychiatry 1990;47(7):658–662.
Coryell W, Leon AC, Turvey C, Akiskal HS, Mueller T, Endicott J. The significance of psychotic features in manic episodes: a report from the NIMH collaborative study. J Affect Disord 2001;67(1–3):79–88.
Abrams R, Taylor MA. Mania and schizo-affective disorder, main type: a comparison. Am J Psychiatry 1976;133(12): 445–447.
Coryell W, Tsuang MT, McDaniel J. Psychotic features in major depression. Is mood congruence important? J Affect Disord 1982;4(3):227–236.
Rosenthal NE, Rosenthal LN, Stallone F, Dunner DL, Fieve RR. Toward the validation of RDC schizoaffective disorder. Arch Gen Psychiatry 1980;37(7):804–810.
Bocchetta A, Bernardi F, Garau L, et al. Familial rates of affective illness in Sardinia with special reference to schizoaffective disorder. Eur Arch Psychiatry Clin Neurosci 1990;240(1):16–20.
Gershon ES, DeLisi LE, Hamovit J, et al. A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 1988;45(4):328–336.
Post RM, Uhde TW. Carbamazepine in bipolar illness. Psychopharmacol Bull 1985;21(1):10–17.
Coryell W, Zimmerman M. The heritability of schizophrenia and schizoaffective disorder. A family study. Arch Gen Psychiatry 1988;45(4):323–327.
Kendler KS, Gruenberg AM, Tsuang MT. Psychiatric illness in first-degree relatives of schizophrenic and surgical control patients. A family study using DSM-III criteria. Arch Gen Psychiatry 1985;42(8):770–779.
Maj M, Starace F, Pirozzi R. A family study of DSM-III-R schizoaffective disorder, depressive type, compared with schizophrenia and psychotic and nonpsychotic major depression. Am J Psychiatry 1991;148(5):612–616.
Angst J. The etiology and nosology of endogenous depressive psychoses. Foreign Psychiatry 1973;2:1–108.
Tsuang MT, Dempsey M, Rauscher F. A study of “atypical schizophrenia”. Comparison with schizophrenia and affective disorder by sex, age of admission, precipitant, outcome, and family history. Arch Gen Psychiatry 1976;33(10):11,157–11,160.
Suslak L, Shopsin B, Silbey E, Mendlewicz J, Gershon S. Genetics of affective disorders. I. Familial incidence study of bipolar, unipolar and schizo-affective illnesses. Neuropsychobiology 1976;2(1):18–27.
Tsuang MT, Dempsey GM, Dvoredsky A, Struss A. A family history study of schizo-affective disorder. Biol Psychiatry 1977;12(3):331–338.
Mendlewicz J, Linkowski P, Wilmotte J. Relationship between schizoaffective illness and affective disorders or schizophrenia. Morbidity risk and genetic transmission. J Affect Disord 1980;2(4):289–302.
Scharfetter C. Subdividing the functional psychoses: a family hereditary approach. Psychol Med 1981;11(3):637–640.
Baron M, Gruen R, Asnis L, Kane J. Schizoaffective illness, schizophrenia and affective disorders: morbidity risk and genetic transmission. Schizoaffective illness, Acta Psychiatr Scand Schizoaffective illness, 1982;65(4):253–262.
Kendler KS, McGuire M, Gruenberg AM, Walsh D. Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study. Am J Psychiatry 1995;152(5):755–764.
Maier W, Lichtermann D, Minges J, et al. Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Arch Gen Psychiatry 1993;50(11): 871–883.
Taylor MA, Berenbaum SA, Jampala VC, Cloninger CR. Are schizophrenia and affective disorder related? Preliminary data from a family study. Am J Psychiatry 1993;150(2): 278–285.
Coryell W, Tsuang MT. DSM-III schizophreniform disorder. Comparisons with schizophrenia and affective disorder. Arch Gen Psychiatry 1982;39(1):66–69.
Abrams R, Taylor MA. The importance of mood-incongruent psychotic symptoms in melancholia. J Affect Disord 1983;5(2):179–181.
Endicott J, Nee J, Coryell W, Keller M, Andreasen N, Croughan J. Schizoaffective, psychotic, and nonpsychotic depression: differential familial association. Compr Psychiatry 1986;27(1):1–13.
Cohen SM, Allen MG, Pollin W, Hrubec Z. Relationship of schizo-affective psychosis to manic depressive psychosis and schizophrenia. Findings in 15,909 veteran pairs. Arch Gen Psychiatry 1972;26(6):539–546.
Tsuang MT. Genetics of affective disorder. New York: Spectrum; 1975.
Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P. A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry 2002;159(4):539–545.
Laursen TM, Labouriau R, Licht RW, Bertelsen A, Munk-Olsen T, Mortensen PB. Family history of psychiatric illness as a risk factor for schizoaffective disorder: a Danish register-based cohort study. Arch Gen Psychiatry 2005;62(8):841–848.
Maziade M, Roy MA, Chagnon YC, et al. Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in Eastern Quebec families. Mol Psychiatry 2005;10(5):486–499.
Wildenauer DB, Schwab SG, Maier W, Detera-Wadleigh SD. Do schizophrenia and affective disorder share susceptibility genes? Schizophr Res 1999;39(2):107–111; discussion 60.
Kendler KS, Gruenberg AM, Tsuang MT. A DSM-III family study of the nonschizophrenic psychotic disorders. Am J Psychiatry 1986;143(9):1098–1105.
Brockington IF, Leff JP. Schizo-affective psychosis: definitions and incidence. Psychol Med 1979;9(1):91–99.
Regier DA, Myers JK, Kramer M, et al. The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. Arch Gen Psychiatry 1984;41(10):934–941.
Weissman MM, Myers JK. Affective disorders in a US urban community: the use of research diagnostic criteria in an epidemiological survey. Arch Gen Psychiatry 1978;35(11): 1304–1311.
Vernon SW, Roberts RE.Use of the SADS-RDC in a tri-ethnic community survey. Arch Gen Psychiatry 1982;39(1):47–52.
Coryell W, Tsuang MT. Outcome after 40 years in DSM-III schizophreniform disorder. Arch Gen Psychiatry 1986;43(4): 324–328.
Coryell W, Tsuang MT. Major depression with mood-congruent or mood-incongruent psychotic features: outcome after 40 years. Am J Psychiatry 1985;142(4):479–482.
Dysken MW, Kooser JA, Haraszti JS, Davis JM. Clinical usefulness of sodium amobarbital interviewing. Arch Gen Psychiatry 1979;36(7):789–794.
Angst J. [Course of unipolar depressive, bipolar manic-depressive, and schizoaffective disorders. Results of a prospective longitudinal study (author’s transl)]. Fortschr Neurol Psychiatr Grenzgeb 1980;48(1):3–30.
Himmelhoch JM, Fuchs CZ, May SJ, Symons BJ, Neil JF. When a schizoaffective diagnosis has meaning. J Nerv Ment Dis 1981;169(5):277–282.
Moller HJ, Schmid-Bode W, Cording-Tommel C, Wittchen HU, Zaudig M, von Zerssen D. Psychopathological and social outcome in schizophrenia versus affective/schizoaffective psychoses and prediction of poor outcome in schizophrenia. Results from a 5–8 year follow-up. Acta Psychiatr 7(4):379–389.
Grossman LS, Harrow M, Goldberg JF, Fichtner CG. Outcome of schizoaffective disorder at two long-term follow-ups: comparisons with outcome of schizophrenia and affective disorders. Am J Psychiatry 1991;148(10):1359–1365.
Williams PV, McGlashan TH. Schizoaffective psychosis. I. Comparative long-term outcome. Arch Gen Psychiatry 1987;44(2):130–137.
Moller HJ, Bottlender R, Wegner U, Wittmann J, Strauss A. Long-term course of schizophrenic, affective and schizoaffective psychosis: focus on negative symptoms and their impact on global indicators of outcome. Acta Psychiatr Scand Suppl 2000(407):54–57.
Brockington IF, Wainwright S, Kendell RE. Manic patients with schizophrenic or paranoid symptoms. Psychol Med 1980;10(1):73–83.
van Praag HM, Nijo L. About the course of schizoaffective psychoses. Compr Psychiatry 1984;25(1):9–22.
Grossman LS, Harrow M, Fudala JL, Meltzer HY. The longitudinal course of schizoaffective disorders. A prospective follow-up study. J Nerv Ment Dis 1984;172(3):140–149.
Maj M, Arena F, Lovero N, Pirozzi R, Kemali D. Factors associated with response to lithium prophylaxis in DSM III major depression and bipolar disorder. Pharmacopsychiatry 1985;18(5):309–313.
Marneros A, Deister A, Rohde A. The concept of distinct but voluminous groups of bipolar and unipolar diseases. I. Bipolar diseases. Eur Arch Psychiatry Clin Neurosci 1990;240(2):77–84.
Tohen M, Tsuang MT, Goodwin DC. Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features. Am J Psychiatry 1992;149(11):1580–1584.
Brockington IF, Kendell RE, Wainwright S. Depressed patients with schizophrenic or paranoid symptoms. Psychol Med 1980;10(4):665–675.
Coryell W, Zimmerman M. Demographic, historical, and symptomatic features of the nonmanic psychoses. J Nerv Ment Dis 1986;174(10):585–592.
Opjordsmoen S. Long-term course and outcome in unipolar affective and schizoaffective psychoses. Acta Psychiatr Scand 1989;79(4):317–326.
Marneros A, Rohde A, Deister A. The concept of distinct but voluminous groups of bipolar and unipolar diseases. II. Unipolar diseases.Eur Arch Psychiatry Clin Neurosci 1990;240(2):85–89.
Tsuang D, Coryell W. An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder, and schizophrenia. Am J Psychiatry 1993;150(8):1182–1188.
Angst J, Weis P, Grof P, Baastrup PC, Schou M. Lithium prophylaxis in recurrent affective disorders. Br J Psychiatry 1970;116(535):604–614.
Johnson G. Differential response to lithium carbonate in manic depressive and schizo-affective disorders. Dis Nerv Syst 1970;31(9):613–615.
Zall H, Therman PG, Myers JM. Lithium carbonate: a clinical study. Am J Psychiatry 1968;125(4):549–555.
Kendler KS. Mood-incongruent psychotic affective illness. A historical and empirical review. Arch Gen Psychiatry 1991;48(4):362–369.
Conus P, Abdel-Baki A, Harrigan S, Lambert M, McGorry PD. Schneiderian first rank symptoms predict poor outcome within first episode manic psychosis. J Affect Disord 2004;81(3): 259–268.
Maj M. Lithium prophylaxis of schizoaffective disorders: a prospective study. J Affect Disord 1988;14(2):129–135.
Schou M, Juel-Nielsen N, Stromgren E, Voldby H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 1954;17(4): 250–260.
Baastrup PC, Schou M. Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 1967;16(2):162–172.
Aronoff MS, Epstein RS. Factors associated with poor response to lithium carbonate: a clinical study. Am J Psychiatry 1970;127(4):472–480.
Prien RF, Caffey EM Jr, Klett CJ. Factors associated with treatment success in lithium carbonate prophylaxis. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiatry 1974;31(2): 189–192.
Yazici O, Kora K, Ucok A, Tunali D, Turan N. Predictors of lithium prophylaxis in bipolar patients. J Affect Disord 1999;55(2–3):133–142.
Sharma RP, Pandey GN, Janicak PG, Peterson J, Comaty JE, Davis JM. The effect of diagnosis and age on the DST: a metaanalytic approach. Biol Psychiatry 1988;24(5):555–568.
Altamura C, Guercetti G, Percudani M. Dexamethasone suppression test in positive and negative schizophrenia. Psychiatry Res 1989;30(1):69–75.
Newcomer JW, Faustman WO, Whiteford HA, Moses JA Jr, Csernansky JG. Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients. Biol Psychiatry 1991;29(9):855–864.
Saffer D, Metcalfe M, Coppen A. Abnormal dexamethasone suppression test in type II schizophrenia. Br J Psychiatry 1985;147:721–723.
Tandon R, Mazzara C, DeQuardo J, et al. Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome. Biol Psychiatry 1991;29(10):953-964.
Coryell W, Tsuang D. Hypothalamic-pituitary-adrenal axis hyperactivity and psychosis: recovery during an 8-year follow-up. Am J Psychiatry 1992;149(8):1033–1039.
Coryell WH, Zimmerman M. HPA axis hyperactivity and recovery from functional psychoses. Am J Psychiatry 1989;146(4):473–477.
Maj M, Starace F, Kemali D. Prediction of outcome by historical, clinical and biological variables in schizoaffective disorder, depressed type. J Psychiatr Res 1987;21(3):289–295.
Lewis DA, Smith RE. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord 1983;5(4):319–332.
Yago KB, Pitts FN Jr, Burgoyne RW, Aniline O, Yago LS, Pitts AF. The urban epidemic of phencyclidine (PCP) use: clinical and laboratory evidence from a public psychiatric hospital emergency service. J Clin Psychiatry 1981;42(5):193–196.
Flor-Henry P. Psychosis and temporal lobe epilepsy. A controlled investigation.Epilepsia 1969;10(3):363–395.
Slater E, Beard AW, Glithero E. The schizophrenialike psychoses of epilepsy. Br J Psychiatry 1963;109:95–150.
Spiker DG, Weiss JC, Dealy RS, et al. The pharmacological treatment of delusional depression. Am J Psychiatry 1985;142(4):430-436.
Wijkstra J, Lijmer J, Balk FJ, Geddes JR, Nolen WA. Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis. Br J Psychiatry 2006;188: 410–415.
Spiker DG, Kupfer DJ. Placebo response rates in psychotic and nonpsychotic depression. J Affect Disord 1988;14(1): 21–23.
Keller MB, Shapiro RW, Lavori PW, Wolfe N. Relapse in major depressive disorder: analysis with the life table. Arch Gen Psychiatry 1982;39(8):911–915.
Dunner DL, Stallone F, Fieve RR. Prophylaxis with lithium carbonate: an update. Arch Gen Psychiatry 1982;39(11): 1344–1345.
Langfeldt G. The Schizophreniform States. London: Oxford University Press; 1939.
Langfeldt G. Definition of “schizophreniform psychoses”. Am J Psychiatry 1982;139(5):703.
Beiser M, Fleming JA, Iacono WG, Lin TY. Refining the diagnosis of schizophreniform disorder. Am J Psychiatry 1988;145(6):695–700.
Guldberg CA, Dahl AA, Hansen H, Bergem M. Predictive value of the four good prognostic features in DSM-III-R schizophreniform disorder. Acta Psychiatr Scand 1990;82(1): 23–25.
Helzer JE, Brockington IF, Kendell RE. Predictive validity of DSM-III and Feighner definitions of schizophrenia. Acomparison with research diagnosis criteria and CATEGO. Arch Gen Psychiatry 1981;38(7):791–797.
Targum SD.Neuroendocrine dysfunction in schizophreniform disorder: correlation with six-month clinical outcome. Am J Psychiatry 1983;140(3):309–313.
Weinberger DR, DeLisi LE, Perman GP, Targum S, WyattRJ. Computed tomography in schizophreniform disorder and other acute psychiatric disorders. Arch Gen Psychiatry 1982;39(7):778–783.
Fogelson DL, Cohen BM, Pope HG Jr. A study of DSM-III schizophreniform disorder. Am J Psychiatry 1982;139(10):1281–1285.
Schimmelmann BG, Conus P, Edwards J, McGorry PD, Lambert M. Diagnostic stability 18 months after treatment initiation for first-episode psychosis. J Clin Psychiatry 2005;66(10):1239–1246.
Fennig S, Kovasznay B, Rich C, et al. Six-month stability of psychiatric diagnoses in first-admission patients with psychosis. Am J Psychiatry 1994;151(8):1200–1208.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Coryell, W. (2008). Schizoaffective and Schizophreniform Disorders. In: Fatemi, S.H., Clayton, P.J. (eds) The Medical Basis of Psychiatry. Humana Press. https://doi.org/10.1007/978-1-59745-252-6_7
Download citation
DOI: https://doi.org/10.1007/978-1-59745-252-6_7
Publisher Name: Humana Press
Print ISBN: 978-1-58829-917-8
Online ISBN: 978-1-59745-252-6
eBook Packages: MedicineMedicine (R0)